2025. Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. Journal of Health Management and Pharmacy Exploration. 3, 1 (febr. 2025). DOI:https://doi.org/10.52465/johmpe.v3i1.547.